The structure of arylamine N-acetyltransferase from Mycobacterium smegmatis--an enzyme which inactivates the anti-tubercular drug, isoniazid.

Arylamine N-acetyltransferases which acetylate and inactivate isoniazid, an anti-tubercular drug, are found in mycobacteria including Mycobacterium smegmatis and Mycobacterium tuberculosis. We have solved the structure of arylamine N-acetyltransferase from M. smegmatis at a resolution of 1.7 A as a...

Полное описание

Библиографические подробности
Главные авторы: Sandy, J, Mushtaq, A, Kawamura, A, Sinclair, J, Sim, E, Noble, M
Формат: Journal article
Язык:English
Опубликовано: 2002
_version_ 1826261326152859648
author Sandy, J
Mushtaq, A
Kawamura, A
Sinclair, J
Sim, E
Noble, M
author_facet Sandy, J
Mushtaq, A
Kawamura, A
Sinclair, J
Sim, E
Noble, M
author_sort Sandy, J
collection OXFORD
description Arylamine N-acetyltransferases which acetylate and inactivate isoniazid, an anti-tubercular drug, are found in mycobacteria including Mycobacterium smegmatis and Mycobacterium tuberculosis. We have solved the structure of arylamine N-acetyltransferase from M. smegmatis at a resolution of 1.7 A as a model for the highly homologous NAT from M. tuberculosis. The fold closely resembles that of NAT from Salmonella typhimurium, with a common catalytic triad and domain structure that is similar to certain cysteine proteases. The detailed geometry of the catalytic triad is typical of enzymes which use primary alcohols or thiols as activated nucleophiles. Thermal mobility and structural variations identify parts of NAT which might undergo conformational changes during catalysis. Sequence conservation among eubacterial NATs is restricted to structural residues of the protein core, as well as the active site and a hinge that connects the first two domains of the NAT structure. The structure of M. smegmatis NAT provides a template for modelling the structure of the M. tuberculosis enzyme and for structure-based ligand design as an approach to designing anti-TB drugs.
first_indexed 2024-03-06T19:19:37Z
format Journal article
id oxford-uuid:19a04179-4e6d-44b9-a70f-13d2853c4bc1
institution University of Oxford
language English
last_indexed 2024-03-06T19:19:37Z
publishDate 2002
record_format dspace
spelling oxford-uuid:19a04179-4e6d-44b9-a70f-13d2853c4bc12022-03-26T10:49:57ZThe structure of arylamine N-acetyltransferase from Mycobacterium smegmatis--an enzyme which inactivates the anti-tubercular drug, isoniazid.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:19a04179-4e6d-44b9-a70f-13d2853c4bc1EnglishSymplectic Elements at Oxford2002Sandy, JMushtaq, AKawamura, ASinclair, JSim, ENoble, MArylamine N-acetyltransferases which acetylate and inactivate isoniazid, an anti-tubercular drug, are found in mycobacteria including Mycobacterium smegmatis and Mycobacterium tuberculosis. We have solved the structure of arylamine N-acetyltransferase from M. smegmatis at a resolution of 1.7 A as a model for the highly homologous NAT from M. tuberculosis. The fold closely resembles that of NAT from Salmonella typhimurium, with a common catalytic triad and domain structure that is similar to certain cysteine proteases. The detailed geometry of the catalytic triad is typical of enzymes which use primary alcohols or thiols as activated nucleophiles. Thermal mobility and structural variations identify parts of NAT which might undergo conformational changes during catalysis. Sequence conservation among eubacterial NATs is restricted to structural residues of the protein core, as well as the active site and a hinge that connects the first two domains of the NAT structure. The structure of M. smegmatis NAT provides a template for modelling the structure of the M. tuberculosis enzyme and for structure-based ligand design as an approach to designing anti-TB drugs.
spellingShingle Sandy, J
Mushtaq, A
Kawamura, A
Sinclair, J
Sim, E
Noble, M
The structure of arylamine N-acetyltransferase from Mycobacterium smegmatis--an enzyme which inactivates the anti-tubercular drug, isoniazid.
title The structure of arylamine N-acetyltransferase from Mycobacterium smegmatis--an enzyme which inactivates the anti-tubercular drug, isoniazid.
title_full The structure of arylamine N-acetyltransferase from Mycobacterium smegmatis--an enzyme which inactivates the anti-tubercular drug, isoniazid.
title_fullStr The structure of arylamine N-acetyltransferase from Mycobacterium smegmatis--an enzyme which inactivates the anti-tubercular drug, isoniazid.
title_full_unstemmed The structure of arylamine N-acetyltransferase from Mycobacterium smegmatis--an enzyme which inactivates the anti-tubercular drug, isoniazid.
title_short The structure of arylamine N-acetyltransferase from Mycobacterium smegmatis--an enzyme which inactivates the anti-tubercular drug, isoniazid.
title_sort structure of arylamine n acetyltransferase from mycobacterium smegmatis an enzyme which inactivates the anti tubercular drug isoniazid
work_keys_str_mv AT sandyj thestructureofarylaminenacetyltransferasefrommycobacteriumsmegmatisanenzymewhichinactivatestheantituberculardrugisoniazid
AT mushtaqa thestructureofarylaminenacetyltransferasefrommycobacteriumsmegmatisanenzymewhichinactivatestheantituberculardrugisoniazid
AT kawamuraa thestructureofarylaminenacetyltransferasefrommycobacteriumsmegmatisanenzymewhichinactivatestheantituberculardrugisoniazid
AT sinclairj thestructureofarylaminenacetyltransferasefrommycobacteriumsmegmatisanenzymewhichinactivatestheantituberculardrugisoniazid
AT sime thestructureofarylaminenacetyltransferasefrommycobacteriumsmegmatisanenzymewhichinactivatestheantituberculardrugisoniazid
AT noblem thestructureofarylaminenacetyltransferasefrommycobacteriumsmegmatisanenzymewhichinactivatestheantituberculardrugisoniazid
AT sandyj structureofarylaminenacetyltransferasefrommycobacteriumsmegmatisanenzymewhichinactivatestheantituberculardrugisoniazid
AT mushtaqa structureofarylaminenacetyltransferasefrommycobacteriumsmegmatisanenzymewhichinactivatestheantituberculardrugisoniazid
AT kawamuraa structureofarylaminenacetyltransferasefrommycobacteriumsmegmatisanenzymewhichinactivatestheantituberculardrugisoniazid
AT sinclairj structureofarylaminenacetyltransferasefrommycobacteriumsmegmatisanenzymewhichinactivatestheantituberculardrugisoniazid
AT sime structureofarylaminenacetyltransferasefrommycobacteriumsmegmatisanenzymewhichinactivatestheantituberculardrugisoniazid
AT noblem structureofarylaminenacetyltransferasefrommycobacteriumsmegmatisanenzymewhichinactivatestheantituberculardrugisoniazid